Cargando…
Phosphoinositide Conversion Inactivates R‐RAS and Drives Metastases in Breast Cancer
Breast cancer is the most prevalent cancer and a major cause of death in women worldwide. Although early diagnosis and therapeutic intervention significantly improve patient survival rate, metastasis still accounts for most deaths. Here it is reported that, in a cohort of more than 2000 patients wit...
Autores principales: | Li, Huayi, Prever, Lorenzo, Hsu, Myriam Y., Lo, Wen‐Ting, Margaria, Jean Piero, De Santis, Maria Chiara, Zanini, Cristina, Forni, Marco, Novelli, Francesco, Pece, Salvatore, Di Fiore, Pier Paolo, Porporato, Paolo Ettore, Martini, Miriam, Belabed, Hassane, Nazare, Marc, Haucke, Volker, Gulluni, Federico, Hirsch, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948670/ https://www.ncbi.nlm.nih.gov/pubmed/35098698 http://dx.doi.org/10.1002/advs.202103249 |
Ejemplares similares
-
Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
por: Li, Huayi, et al.
Publicado: (2021) -
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer
por: De Santis, Maria Chiara, et al.
Publicado: (2023) -
Antagonistic control of active surface integrins by myotubularin and phosphatidylinositol 3-kinase C2β in a myotubular myopathy model
por: Samsó, Paula, et al.
Publicado: (2022) -
Phosphoinositides as membrane organizers
por: Posor, York, et al.
Publicado: (2022) -
Signaling Pathways Regulating Redox Balance in Cancer Metabolism
por: De Santis, Maria Chiara, et al.
Publicado: (2018)